Entry to the U.S. requires more proof of vaccination than should be necessary, while unvaccinated people are free to fly anywhere within the country.
Max NisenEquity Associate Analyst
In a shift toward much-needed flexibility, drug regulators will enable all Americans seeking greater protection against Covid-19 to easily get it.
The former military officer and statesman needed as many people around him as possible to be vaccinated to diminish his chances of encountering the virus.
It should also be relatively easy to scale up manufacturing and get pills out to the people who need them worldwide.
One attempt to repair a faulty eye gene had disappointing results, but the technology can be expected to one day treat all sorts of genetic diseases.
Highly convenient oral drugs could be a pandemic game changer. With enough investment, the U.S. could make a whole lot of them for the world.
From the need for boosters to kids and Covid and the risk of new variants, here’s what you need to know.
Setting a timeline before experts weighed in put improper pressure on scientific agencies, raised expectations and now risks creating confusion when the focus should be on first shots.
The airline is the first major corporation to say it will slap a big health-insurance surcharge on workers who haven’t had their Covid-19 shots. Is this a good idea?
The rise of the delta variant makes testing more important than ever, even among the vaccinated. Rapid antigen tests are the right tool for the job.
The company needs to put its Covid vaccine windfall to use, but it has outlined an acquisition strategy that won't pay off anytime soon.
The World Health Organization is right to call for a halt to booster shots until more people in the developing world get their first vaccinations.
U.S. vaccination rates are still too low. Employers could start offering health-insurance discounts as an incentive to get a shot.